Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer

Clinical trial NCT00072033 · COMPLETED

Trial details

NCT number: NCT00072033
Sponsor: Swiss Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer

Start date: 2003-03-01
Primary completion: 2003-03-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.